<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">Disulfiram (
 <bold>19</bold>), an approved drug for the treatment of chronic alcohol dependence, has a great potential for drug repurposing because it has been shown to inhibit PLpro of MERS-CoV and SARS-CoV.
 <xref rid="bib26" ref-type="bibr">
  <sup>26</sup>
 </xref> The antimetabolites 6-mercaptopurine (
 <bold>20</bold>) and 6-thioguanine (
 <bold>21</bold>) are additional drugs inhibiting PLpro (
 <xref rid="sch3" ref-type="fig">Scheme 3</xref> ).
</p>
